ORTHODONTICS

The consent dilemma
Sir, I write in response to the opinion article Truth or consequences: the potential implications of short-term cosmetic orthodontics for general practitioners (BDJ 2013; 215: 551-553). The author makes some very interesting and relevant points on the clinical benefits and short-comings of 'quick-fix' orthodontics. They also clearly demonstrate the growing market for this type of orthodontic treatment.
I concentrate on the principle of obtaining informed consent. One essential component of obtaining 'valid' informed consent is to provide the patient with all treatment options, risks, their respective advantages and disadvantages and likely long term prognosis. The question I pose is: is the general dental practitioner equipped with enough orthodontic specialist knowledge to make the consent process valid? For example, a patient presents with mild labial crowding of the lower buccal segment. The patient wishes to proceed with orthodontic treatment. Have all the options been explored? Have the advantages and disadvantages of fixed appliances and labial appliances been discussed? Have their benefits and prognosis been discussed; has the patient had the opportunity to compare these to the benefits and prognosis of clear aligners, for example? If the patient has only been given the option of a clear aligner, has the GDP gained 'valid' informed consent? The author highlights the clinical implications of the 'quickfix' orthodontic appliances as well as the unfavourable tooth movements which may be more amenable to relapse. Are these risks highlighted at the beginning of the treatment plan? Of course if these questions have been addressed then the patient has the choice to go forward with a treatment option which suits them and their circumstances. However, the ethical dilemma presents itself when these issues were not addressed or were not addressed sufficiently due to lack of specialist knowledge. Was the consent process, therefore, legally sufficient?
The success of clear aligner technology is a great orthodontic treatment option for many patients, in particular adults. It most definitely has a place in both general and specialist practice. However, this is only one treatment option and it is imperative for the practitioner to inform patients of all options and relative prognosis for both legal and moral reasons. 
DRUGS Fraught interactions
Sir, the paper on drug interactions marks a significant contribution to this potentially fraught area relevant to clinical practice. 1 It might be helpful to remind practitioners of the drug (medication) issues relevant to patient age. 2 Not only are older individuals generally more susceptible to drug effects, but there are also potential issues with children -in whom there are the wellrecognised dental risks from agents such as tetracyclines -but also the need to avoid aspirin and other non-steroidal analgesics because of the potential to develop potentially lethal liver and brain damage (Reye syndrome), and also the potential hazards from use of codeine.
Since 2012, it has been recognised and flagged up in alerts by the US Food and Drug Administration (FDA) that some children have died post-operatively after being given codeine in amounts within the recommended dose range. 3 Codeine is hepatically converted to morphine by the liver and some children genetically are ultrarapid metabolisers who convert codeine into potentially fatal amounts of morphine.
Paracetamol (acetaminophen) is an alternate analgesic, very widely used and with a well-established record of safety and efficacy. However, the FDA is now asking doctors to stop prescribing medications that have more than 325 mg of paracetamol/ acetaminophen per adult dose, because of its potential hepatotoxicity at larger doses. 4 Most cases of severe liver damage have been in patients who have taken more than the prescribed dose of a paracetamol-
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containing product over a 24-hour period or who have taken more than one paracetamol-containing product at once and/or who have drunk alcohol while taking the paracetamol.
C. Scully London 1 2014 marks the anniversary of a new epidemic in the UK of middle aged adults with untreated part-erupted mesioangular impacted lower third molars associated with unrestorable distal cervical caries in the adjacent second molar. [2] [3] [4] [5] We all recognise this symptom complex but so far it lacks a name and hence it has limited clinical acceptance. It is high time we put this right, and I propose it is named the Shepherd Brickley Syndrome in tribute to the two protagonists of non-prophylactic wisdom tooth management who introduced this epidemic to British dentistry 20 years ago. 6 J. Townend Chichester DOI: 10.1038/sj.bdj.2014.106
EBD Squirting sockets
Sir, I was a little disturbed to see the suggestion that 'there is some evidence that rinsing with chlorhexidine or placing chlorhexidine gel in the sockets of extracted teeth provides a benefit in preventing dry socket' in the Evidence Based Dentistry 'toolbox' . 1 I have some misgivings about this advice. If chlorhexidine gel is placed in all extraction sockets, what is the likelihood of seeing serious adverse side effects such as anaphylaxis, especially since the use of chlorhexidine (and consequent sensitisation) has become so widespread?
Is this a licensed and safe use of chlorhexidine gel?
Is it wise to use gel from a toothpaste tube parenterally?
If a serious adverse reaction occurred, would our treatment be defensible in court?
I note that some of the papers 2 reviewed by the Cochrane team mention using gelatine sponges. I haven't used these since the 1970s as I have doubts about sterility and the advisability of using bovine-based materials in some religious and other groups, to say nothing of BSE.
I would draw readers' attention to the last line of the Cochrane Review, 3 not included in the toolbox, namely that 'it is recommended that all members of the dental team prescribing chlorhexidine products are aware of the potential for both minor and serious adverse side effects' .
All things considered it's probably not a good idea to squirt chlorhexidine gel into fresh tooth sockets. There were 26 people in our year at Queen's University Dental School. Paul was one who committed suicide in December and two months ago another colleague, also our year, committed suicide. Both have pointed to pressures from the dental boards and, in N. Ireland, pressures from the RQIA and Dental Probity. This, I think you would agree, is quite a high proportion, two out of 26.
Over the last ten years in N. Ireland there have been a number of dental suicides. As yet, I am not aware of any 'minister of state for health opening any enquiry into the dental board, BSO or probity department here in N. Ireland' and starting to make them take accountability for their actions.
Perhaps the BDA could take action on this here in Northern Ireland.
M. Haran By email DOI: 10.1038/sj.bdj.2014.108
